Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

OptiBiotix Health PLC

OPTI.L ✓ COMPLIANTFree checks used up today ☆ Track — members

LSE · Healthcare · Biotechnology & Medical Research ·

UK Micro Cap Analyst: N/A

Last Close

$0.07

▼ -4.24%

Market Cap $7.71M · Vol 356.26K

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$7.71M

Micro Cap

Div Yield

N/A

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

16.67

Momentum

Beta

2.76

vs Market

52W High

$0.13

43.35% below

52W Low

$0.06

23.10% above

Volume

356.26K

Avg 255.77K

P/B

1.11

Price-to-book

ROE

N/A

Return on equity

Free Float

84.09%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, OptiBiotix Health PLC (OPTI.L) stock is Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does OPTI.L pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-4.24%

-11.02%

-11.72%

+5.61%

YTD

-16.30%

-42.05%

-76.73%

-82.70%

Financials & Valuation

TTM · Annual

Total Revenue	$1.57M
Net Income	$-5,240,963.00
Revenue Growth (YoY)	+21.90%
Gross Margin	52.66%
Operating Margin	-268.61%
Net Profit Margin	-333.62%
ROE	N/A
ROA · ROIC	-49.48% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	5.86
P/B	1.11
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	103.30M

Technical Indicators

50-Day SMA	$0.08
200-Day SMA	$0.08
RSI (14)	16.67
Beta	2.76
52-Week High	$0.13
52-Week Low	$0.06

Volume Today	356.26K
Avg Daily Volume (30D)	255.77K
Relative Volume	1.39x
Volatility (10D)	21.37
Volatility (30D)	56.09
Free Float	84.09%

Analyst Consensus

N/A

Current Price $0.07

Mean Target N/A

52W Low$0.06 52W High$0.13

Current

Target

$0.06 $0.13

Current Analyst target

· 0 analysts

Identifiers

ExchangeLSE

FIGIBBG00217M8R7

ISINGB00BP0RTP38

CountryUK

Sub-IndustryBio Therapeutic Drugs

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

2359.HK WuXi AppTec Co., Ltd. -0.19% ARGX.BR argenx SE -1.99% ARGX argenx SE -1.19% 2269.HK WuXi Biologics (Cayman) Inc. -2.66% GMAB Genmab A/S -2.14%

Company Profile

OptiBiotix Health Plc is a life sciences company. The Company is engaged in the development of microbial strains, compounds, and formulations, which are used as active ingredients and supplements. It is focused on the development of products which reduce hunger and food cravings, enhance the gut microbiome, and provide a healthy substitute for sugar. It is also developing its own range of consumer supplements and health products. Its areas of focus include obesity, cardiovascular health, and diabetes. Its products include SlimBiome, CholBiome, SweetBiotix, WellBiome, OptiBiotics and SlimBiome X3. SlimBiome offers a natural, scientifically supported, non-pharmaceutical approach to reducing hunger and cravings. CholBiome contains Lactobacillus plantarum LPLDL as the only active ingredient, focusing on healthy cholesterol maintenance and delivering tangible health benefits. SweetBiotix is a zero or low-calorie, prebiotic, and a smarter alternative to sugar and existing sweeteners.